Frozen human frontal cortex primary gray matter was weighed and placed on dry ice. Freshly prepared, ice-cold 5 M Guanidine Hydrochloride in Tris-buffered saline (20 mM Tris-HCl, 150 mM NaCl, pH 7.4 TBS) containing 1:100 Halt protease inhibitor cocktail (Thermo Scientific) and 1:100 Phosphatase inhibitor cocktail 2 & 3 (Sigma, St. Louis, MO) was added to the brain tissue at 5:1 ratio and homogenized with Qiagen Tissue Lyser LT (Qiagen Inc., Germantown, MD) at 50 Hz for 5 minutes. The homogenate was then shaken (regular rocker) overnight at room temperature. The lysate was diluted with 1% Blocker A (Meso Scale Discovery (MSD) #R93BA-4, Rockville, MD) in wash buffer in accordance with the specific ELISA assays: 1:4000 for α-synuclein (MSD #K151TGD-2), 1:300 for total tau and tau phosphorylated at threonine 231 (pTau231; MSD #K15121D-2), and 1:4000 for β-amyloids 1-40 and 1-42 (MSD #K15200E-2). Samples were subsequently spun down at 17,000 g and 4°C for 15 minutes, and the supernatant was applied to the ELISA assays. A standard sandwich ELISA was used to measure tau phosphorylated at threonine 181 (pTau181), with the capturing antibody as AT270 against pTau181 (Thermo Scientific #MN1050) and a well-characterized T46 antibody against total tau as the detecting antibody (Thermo Scientific). Sulfo-tag conjugated anti-mouse secondary antibody (MSD) was used for signal detection by the MSD platform, and an MSD SECTOR S 600 Imager was used to measure analyte levels.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.